Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Entero Healthcare Solutions Limited (ENTERO.BO)

Compare
1,312.95
+1.35
+(0.10%)
At close: 3:29:43 PM GMT+5:30
Loading Chart for ENTERO.BO
  • Previous Close 1,311.60
  • Open 1,310.50
  • Bid 1,320.00 x --
  • Ask 1,320.00 x --
  • Day's Range 1,291.60 - 1,327.00
  • 52 Week Range 991.35 - 1,583.00
  • Volume 3,835
  • Avg. Volume 3,938
  • Market Cap (intraday) 57.123B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 63.37
  • EPS (TTM) 20.72
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1,595.50

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.

www.enterohealthcare.com

3,240

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ENTERO.BO

View More

Performance Overview: ENTERO.BO

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ENTERO.BO
7.71%
S&P BSE SENSEX (^BSESN)
0.53%

1-Year Return

ENTERO.BO
19.41%
S&P BSE SENSEX (^BSESN)
7.69%

3-Year Return

ENTERO.BO
5.46%
S&P BSE SENSEX (^BSESN)
34.65%

5-Year Return

ENTERO.BO
5.46%
S&P BSE SENSEX (^BSESN)
148.67%

Compare To: ENTERO.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENTERO.BO

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    56.99B

  • Enterprise Value

    55.57B

  • Trailing P/E

    63.31

  • Forward P/E

    54.95

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.20

  • Price/Book (mrq)

    3.39

  • Enterprise Value/Revenue

    1.17

  • Enterprise Value/EBITDA

    29.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.88%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    47.91B

  • Net Income Avi to Common (ttm)

    901M

  • Diluted EPS (ttm)

    20.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.03B

  • Total Debt/Equity (mrq)

    20.96%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ENTERO.BO

View More

Company Insights: ENTERO.BO

Research Reports: ENTERO.BO

View More

People Also Watch